コミナティ（トジナメラン）の世界市場レポート 2025年：疫学、パイプライン分析、市場インサイト＆予測

コミナティ（トジナメラン）の市場規模は、今後数年で飛躍的な成長が見込まれます。2029年には179億7,630万米ドルに成長し、CAGRは21%となります。この予測期間における成長は、小児用ワクチンの承認、異種混合ワクチンの需要、低所得地域におけるワクチン入手の容易化、民間ワクチン調達の増加、mRNA技術の新たな治療応用などに起因すると考えられます。予測期間における主要動向としては、mRNAプラットフォームのイノベーションへの注目の高まり、ワクチン製造とAI主導型分析の統合、次世代ワクチンとの競合の激化、ワクチン製造における持続可能性の重視、針を使わないワクチン送達方法の進歩などが挙げられます。

感染症の流行増加は、コミナティ（トジナメラン）市場の成長を大きく促進すると予想されます。細菌、ウイルス、真菌、寄生虫などの病原体によって引き起こされる感染症は、世界の旅行、都市化、気候変動、不十分なヘルスケアアクセスなどの要因により、より広がっています。コミナティ（トジナメラン）は、mRNA技術を活用して効果的な防御を提供することで、感染症、特にCOVID-19の制御に重要な役割を果たしています。感染率を下げ、重症化を防ぎ、入院を最小限に抑えることができます。例えば、英国健康安全保障局は、2023年に麻疹患者が約7倍に増加すると報告しており、感染症と闘うためにコミナティのような効果的なワクチンの必要性が高まっていることを強調しています。その結果、感染症の有病率の上昇がコミルナティの需要を牽引しています。

個別化医療の動向の高まりは、コミルナティ市場の成長を促進すると予想されます。個別化医療は、遺伝的体質、生活習慣、環境などの個人の特性に基づいて治療を調整し、治療成績を向上させるものです。このアプローチは、ゲノミクスの進歩、精密診断、より的を絞った治療への需要により拡大しています。mRNA技術を持つコミルナティは、個人の遺伝子プロファイルに迅速に適応できる柔軟なワクチンプラットフォームを提供することで、この動向をサポートしています。2022年、FDAは新薬の34%について個別化医療を承認しており、個別化医療の採用が増加していることを裏付けています。このように、個別化医療の台頭はコミルナティ市場の成長をさらに促進すると考えられます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のコミナティ（トジナメラン）：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコミナティ（トジナメラン）市場：成長率分析
• 世界のコミナティ（トジナメラン）市場の実績：規模と成長、2019～2024年
• 世界のコミナティ（トジナメラン）市場の予測：規模と成長、2024～2029年、2034年
• 世界のコミナティ（トジナメラン）：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のコミナティ（トジナメラン）市場：配合別、実績と予測、2019～2024年、2024～2029年、2034年
• 従来型
• 脂質ナノ粒子
• その他
• 世界のコミナティ（トジナメラン）市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• COVID-19予防
• COVID-19治療
• 世界のコミナティ（トジナメラン）市場作用機序別、実績と予測、2019～2024年、2024～2029年、2034年
• スパイクタンパク質をコードするmRNA
• 重要成分をコードするmRNA
• 世界のコミナティ（トジナメラン）市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• その他
• 世界のコミナティ（トジナメラン）市場：対象人口別、実績と予測、2019～2024年、2024～2029年、2034年
• 成人
• 幼児（12歳以上）
• 幼児（12歳の子供）

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のコミナティ（トジナメラン）市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のコミナティ（トジナメラン）市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• コミナティ（トジナメラン）市場：競合情勢
• コミナティ（トジナメラン）市場：企業プロファイル
  • Pfizer Inc.
  • BioNTech SE

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• コミナティ（トジナメラン）市場、2029年：新たな機会を提供する国
• コミナティ（トジナメラン）市場、2029年：新たな機会を提供するセグメント
• コミナティ（トジナメラン）市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Comirnaty (tozinameran) is an mRNA-based vaccine developed for the prevention of COVID-19. It uses lipid nanoparticles to deliver mRNA, instructing cells to produce a protein resembling the SARS-CoV-2 spike protein, which triggers an immune response. This helps prevent COVID-19 infection and reduces the severity of the disease, including severe outcomes like hospitalization and death.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main formulations for comirnaty include conventional and lipid nanoparticle-based formats, designed to enhance the delivery and efficacy of the vaccine. The primary indications for this vaccine are COVID-19 prevention and treatment. Comirnaty works by utilizing mRNA that encodes for the spike protein and other key viral components, enabling a precise immune response. It is used in various healthcare settings, including hospitals and clinics, and is intended for adults, children aged 12 and older, and, in some cases, children under 12, ensuring broad accessibility for diverse age groups.

The comirnaty (tozinameran) market research report is one of a series of new reports from The Business Research Company that provides comirnaty (tozinameran) market statistics, including comirnaty (tozinameran) industry global market size, regional shares, competitors with a comirnaty (tozinameran) market share, detailed comirnaty (tozinameran) market segments, market trends and opportunities, and any further data you may need to thrive in the comirnaty (tozinameran) industry. This comirnaty (tozinameran) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The comirnaty (tozinameran) market size is expected to see exponential growth in the next few years. It will grow to $17,976.3 million in 2029 at a compound annual growth rate (CAGR) of 21%. The growth in the forecast period can be attributed to authorization for pediatric use, demand for variant-specific vaccines, increased vaccine accessibility in low-income regions, increasing private sector vaccine procurement, and emerging therapeutic applications of mRNA technology. Major trends in the forecast period include growing focus on mRNA platform innovations, integration of vaccine production with AI-driven analytics, increasing competition from next-generation vaccines, focus on sustainability in vaccine production, and advancements in needle-free vaccine delivery methods.

The increasing prevalence of infectious diseases is expected to significantly drive the growth of the comirnaty (tozinameran) market. Infectious diseases, caused by pathogens like bacteria, viruses, fungi, or parasites, are spreading more due to factors such as global travel, urbanization, climate change, and inadequate healthcare access. Comirnaty (tozinameran) plays a crucial role in controlling infectious diseases, especially COVID-19, by leveraging mRNA technology to provide effective protection. It helps reduce transmission rates, prevent severe cases, and minimize hospitalizations. For instance, the UK Health Security Agency reported a nearly sevenfold increase in measles cases in 2023, which highlights the growing need for effective vaccines like Comirnaty to combat infectious diseases. As a result, the rising prevalence of infectious diseases is driving the demand for comirnaty.

Rising trends in personalized medicine are expected to propel the growth of the comirnaty market. Personalized medicine tailors treatments based on individual characteristics such as genetic makeup, lifestyle, and environment to improve treatment outcomes. This approach is growing due to advancements in genomics, precision diagnostics, and the demand for more targeted therapies. Comirnaty, with its mRNA technology, supports this trend by providing a flexible vaccine platform that can be rapidly adapted to meet individual genetic profiles. In 2022, the FDA approved personalized medicines for 34% of new drugs, underscoring the increasing adoption of personalized medicine. Thus, the rise of personalized medicine will further fuel the growth of the comirnaty market.

A key trend in the comirnaty market is the development of innovative products such as the bivalent mRNA COVID-19 vaccine, which provides enhanced protection against both the original virus and emerging variants like Omicron. Bivalent vaccines are designed to target both the original SARS-CoV-2 strain and specific variants, improving immune response and offering broader protection. In December 2023, the Therapeutic Goods Administration in Australia approved Pfizer's COMIRNATY Original/Omicron BA.4-5 COVID-19 Vaccine as a booster for individuals aged 5 years and older. This approval reflects the growing trend of adapting vaccines to target evolving strains, ensuring continued effectiveness against emerging COVID-19 variants and strengthening global public health resilience.

Major players operating in the comirnaty (tozinameran) market are Pfizer Inc.; BioNTech SE

North America was the largest region in the comirnaty (tozinameran) market in 2024. The regions covered in comirnaty (tozinameran) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the comirnaty (tozinameran) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The comirnaty (tozinameran) market consists of sales of multidose vials, single-dose prefilled syringes, and combination products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Comirnaty (Tozinameran) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on comirnaty (tozinameran) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comirnaty (tozinameran) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The comirnaty (tozinameran) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Formulation: Conventional; Lipid Nanoparticles; Other Formulations
• 2) By Indication: COVID-19 Prevention; COVID-19 Treatment
• 3) By Mechanism Of Action: mRNA Coding For Spike Protein; mRNA Coding For Vital Components
• 4) By Application: Hospital; Clinic; Other
• 5) By Intended Population: Adults; Children (>=12 Years); Children (12 Years)
• Companies Mentioned: Pfizer Inc.; BioNTech SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Comirnaty (Tozinameran) Market Characteristics

3. Comirnaty (Tozinameran) Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Comirnaty (Tozinameran) Market Trends And Strategies

5. Comirnaty (Tozinameran) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Comirnaty (Tozinameran) Growth Analysis And Strategic Analysis Framework

• 6.1. Global Comirnaty (Tozinameran) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Comirnaty (Tozinameran) Market Growth Rate Analysis
• 6.4. Global Comirnaty (Tozinameran) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Comirnaty (Tozinameran) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Comirnaty (Tozinameran) Total Addressable Market (TAM)

7. Global Comirnaty (Tozinameran) Market Pricing Analysis & Forecasts

8. Comirnaty (Tozinameran) Market Segmentation

• 8.1. Global Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional
• Lipid Nanoparticales
• Other Formulations
• 8.2. Global Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• COVID-19 Prevention
• COVID-19 Treatment
• 8.3. Global Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• mRNA Coding For Spike Protein
• mRNA Coding For Vital Components
• 8.4. Global Comirnaty (Tozinameran) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other Applications
• 8.5. Global Comirnaty (Tozinameran) Market, Segmentation By Intended Population, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adults
• Children (>=12 Years)
• Children (12 Years)

9. Global Comirnaty (Tozinameran) Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Comirnaty (Tozinameran) Market Regional And Country Analysis

• 10.1. Global Comirnaty (Tozinameran) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Comirnaty (Tozinameran) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Comirnaty (Tozinameran) Market

• 11.1. Asia-Pacific Comirnaty (Tozinameran) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Comirnaty (Tozinameran) Market

• 12.1. China Comirnaty (Tozinameran) Market Overview
• 12.2. China Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Comirnaty (Tozinameran) Market

• 13.1. India Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Comirnaty (Tozinameran) Market

• 14.1. Japan Comirnaty (Tozinameran) Market Overview
• 14.2. Japan Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Comirnaty (Tozinameran) Market

• 15.1. Australia Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Comirnaty (Tozinameran) Market

• 16.1. South Korea Comirnaty (Tozinameran) Market Overview
• 16.2. South Korea Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Comirnaty (Tozinameran) Market

• 17.1. Western Europe Comirnaty (Tozinameran) Market Overview
• 17.2. Western Europe Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Comirnaty (Tozinameran) Market

• 18.1. UK Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Comirnaty (Tozinameran) Market

• 19.1. Germany Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Comirnaty (Tozinameran) Market

• 20.1. France Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Comirnaty (Tozinameran) Market

• 21.1. Eastern Europe Comirnaty (Tozinameran) Market Overview
• 21.2. Eastern Europe Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Comirnaty (Tozinameran) Market

• 22.1. North America Comirnaty (Tozinameran) Market Overview
• 22.2. North America Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Comirnaty (Tozinameran) Market

• 23.1. USA Comirnaty (Tozinameran) Market Overview
• 23.2. USA Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Comirnaty (Tozinameran) Market

• 24.1. Canada Comirnaty (Tozinameran) Market Overview
• 24.2. Canada Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Comirnaty (Tozinameran) Market

• 25.1. South America Comirnaty (Tozinameran) Market Overview
• 25.2. South America Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Comirnaty (Tozinameran) Market

• 26.1. Middle East Comirnaty (Tozinameran) Market Overview
• 26.2. Middle East Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Comirnaty (Tozinameran) Market

• 27.1. Africa Comirnaty (Tozinameran) Market Overview
• 27.2. Africa Comirnaty (Tozinameran) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Comirnaty (Tozinameran) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Comirnaty (Tozinameran) Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Comirnaty (Tozinameran) Market Competitive Landscape And Company Profiles

• 28.1. Comirnaty (Tozinameran) Market Competitive Landscape
• 28.2. Comirnaty (Tozinameran) Market Company Profiles
  • 28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

29. Global Comirnaty (Tozinameran) Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Comirnaty (Tozinameran) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Comirnaty (Tozinameran) Market

32. Recent Developments In The Comirnaty (Tozinameran) Market

33. Comirnaty (Tozinameran) Market High Potential Countries, Segments and Strategies

• 33.1 Comirnaty (Tozinameran) Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Comirnaty (Tozinameran) Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Comirnaty (Tozinameran) Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer